Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
  1. 4 Planned sale Chief Legal Officer and GC sold 2,994 shares at an average $32.18 ($96,359)
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 100,087 shares at an average $32.28 ($3,230,316)
  11. 4 Open-market sale CHIEF MEDICAL OFFICER sold 6,956 shares at $32.12 ($223,427)
  12. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 7,242 shares at $32.12 ($232,613)
  13. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 7,310 shares at $32.12 ($234,797)
  14. 4 Planned sale Chief Research Officer sold 12,446 shares at $32.87 ($409,100)
  15. 4 Open-market sale SVP, CHIEF ACCOUNTING OFFICER sold 4,333 shares at $32.12 ($139,176)
  16. 4 Open-market sale Chief Legal Officer and GC sold 7,175 shares at $32.12 ($230,461)
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 60,000 shares at an average $30.09 ($1,805,134)
  20. 144 Insider Sale of Securities

Page 8 of 65 · 1,286 filings